These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8117382)

  • 1. Synthesis and pharmacological evaluation of a new class of 2-oxo-8-azaspiro (4,5)decan-1-ones as analogues of the muscarinic agonist RS-86.
    Cignarella G; Villa S; Barlocco D
    Farmaco; 1993 Oct; 48(10):1439-45. PubMed ID: 8117382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-(Substituted)amino-2,8-diazaspiro[4,5]decan-1,3-diones as potential muscarinic agonists: synthesis, modeling and binding studies.
    Barlocco D; Fanelli F; Cignarella G; Villa S; Cattabeni F; Balduini W; Cimino M; De Benedetti PG
    Drug Des Discov; 1996 Oct; 14(2):129-43. PubMed ID: 9010619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central cholinergic agents. III. Synthesis of 2-alkoxy-2,8- diazaspiro[4.5]decane-1,3-diones as muscarinic agonists.
    Ishihara Y; Yukimasa H; Miyamoto M; Goto G
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1177-85. PubMed ID: 1394631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
    Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
    Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists.
    Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(3):209-14. PubMed ID: 1163240
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and anticonvulsant properties of new N-phenylamino derivatives of 2-azaspiro[4.4]nonane, 2-azaspiro[4.5]decane-1,3-dione and 3-cyclohexylpyrrolidine-2,5-dione. Part IV.
    Obniska J; Kamiński K
    Acta Pol Pharm; 2006; 63(2):101-8. PubMed ID: 17514872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-antigastrin activity relationships of new spiroglumide amido acid derivatives.
    Makovec F; Peris W; Frigerio S; Giovanetti R; Letari O; Mennuni L; Revel L
    J Med Chem; 1996 Jan; 39(1):135-42. PubMed ID: 8568800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity studies of a series of 1-oxa-8-azaspiro[4.5]decanes as M1 muscarinic agonists.
    Tsukamoto S; Fujii M; Yasunaga T; Matsuda K; Wanibuchi F; Hidaka K; Furuya T; Tamura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):842-52. PubMed ID: 7553970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione.
    Obniska J; Kołaczkowski M; Bojarski AJ; Duszyńska B
    Eur J Med Chem; 2006 Jul; 41(7):874-81. PubMed ID: 16600439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, physicochemical and anticonvulsant properties of new N-phenylamino derivatives of 2-azaspiro[4.4]nonane- and [4.5]decane-1,3-diones: part V.
    Kamiński K; Obniska J; Dybała M
    Eur J Med Chem; 2008 Jan; 43(1):53-61. PubMed ID: 17475369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the cholinergic receptor. IV. The synthesis and muscarinic activity of 3,7-dimethyl-2,4-dioxo-7-azaspiro[3.4]octane methiodide.
    Ridley HF; Chatterjee SS; Moran JF; Triggle DJ
    J Med Chem; 1969 Sep; 12(5):931-3. PubMed ID: 5812223
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954.
    Wanibuchi F; Konishi T; Harada M; Terai M; Hidaka K; Tamura T; Tsukamoto S; Usuda S
    Eur J Pharmacol; 1990 Oct; 187(3):479-86. PubMed ID: 1963596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular requirements of the active sites of the cholinergic receptors. XVI - Synthesis and cholinergic activity of 2- or 5-alkyl or 5-phenyl-4-methyl-3-oxo-1-dimethylaminomethylcyclopentane methiodide.
    Pigini M; Brasili L
    Farmaco Sci; 1981 Feb; 36(2):152-8. PubMed ID: 7227502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of some 6-substituted 7-methyl-1,4-dioxa-7-azaspiro[4.5]decanes as potential dopamine agonists.
    Brubaker AN; Colley M
    J Med Chem; 1986 Aug; 29(8):1528-31. PubMed ID: 3735319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New cyclohexane 3-spirobutenolide acid aminoesters: synthesis and pharmacological approach].
    Paris J; Bastide J; Bastide P
    Ann Pharm Fr; 1983 Feb; 40(5):465-71. PubMed ID: 6847080
    [No Abstract]   [Full Text] [Related]  

  • 16. One-step synthesis and pharmacological activity of new (N-substituted)amino-spiroalkan-dione derivatives.
    Bonsignore L; Loy G; Cottiglia F; Calignano A
    Farmaco; 1997 Nov; 52(11):663-6. PubMed ID: 9550091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structure- and conformation-activity relationships of heterocyclic acetylcholine analogues. 16. Conformational behaviour and cholinergic properties of isoarecaidine and sulfoisoarecaidine esters].
    Höltje HD; Lambrecht G; Moser U; Mutschler E
    Arzneimittelforschung; 1983; 33(2):190-7. PubMed ID: 6601954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic compounds. III - Synthesis and biological activity of epi-desmethyldesethermuscarine, desmethyldesethermuscarine and desmethyldesethermuscarone.
    Melchiorre C; Gualtieri F; Giannella M; Pigini M; Cingolani ML; Gamba G; Pigini P; Rossini L
    Farmaco Sci; 1975 Apr; 30(4):287-99. PubMed ID: 1183606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivatives of 3-p-chlorophenyl-3-oxopropane and 3-p-chlorophenyl-3-hydroxypropane-1-carboxylic acids.
    Jakóbiec T; Milian A; Zawisza T
    Pol J Pharmacol Pharm; 1976; 28(5):537-44. PubMed ID: 1012980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: I. In vitro pharmacological characterization and pharmacokinetic properties.
    Valenzano KJ; Miller W; Chen Z; Shan S; Crumley G; Victory SF; Davies E; Huang JC; Allie N; Nolan SJ; Rotshteyn Y; Kyle DJ; Broglé K
    J Pharmacol Exp Ther; 2004 Aug; 310(2):783-92. PubMed ID: 15054115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.